Atlantic examines obesity treatment access gap in GLP-1 era
The feature focuses on disparities in which patients with obesity actually receive GLP-1 therapies.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 17 07:32 ETSource: The Atlantic
The wire
- 01The Atlantic published a piece on access disparities for obesity patients amid GLP-1 demand.
- 02Highlights gap between clinical eligibility and real-world availability of the drugs.
- 03Policy or coverage remedies discussed are not specified in the excerpt.
From the source
Read at news.google.comThe Access Gap: Treating Patients with Obesity in the GLP-1 Era